category eurecat unit
Eurecat develops the first biophotonic implant to deliver therapeutic proteins to Multiple Sclerosis patients
The Eurecat technology centre has developed, within the Optogenerapy consortium, the first subcutaneous biophotonic implant using optogenetic technology to deliver doses of therapeutic proteins to patients with Multiple Sclerosis. The device has been pre-clinically validated and features a printed circuit board that activates a light source which controls therapeutic Interferon Beta (IFN-ß) protein production by genetically engineered [...]